Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Arcellx, Inc. | 2,095,114 | reported | 08 Feb 2022 | tx 3+2,095,114−2,095,114 |
| FIVE PRIME THERAPEUTICS INC | 455,336 | reported | 01 Sept 2019 | tx 96+1,214,706−1,057,340 |
| Neurogene Inc. | 25,000 | reported | 11 May 2021 | tx 3+72,000 |
| Protagonist Therapeutics, Inc | 7,825 | reported | 17 Feb 2026 | tx 15+210,871−18,000 |
| BECKMAN COULTER INC |
| 0 |
| reported |
| 30 Jun 2011 |
| tx 30+11,179.28−11,191.09 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | EXERCISE | Protagonist Therapeutics, Inc | 18,000 | 10.84 USD | |
| 17 Feb 2026 | SALE | Protagonist Therapeutics, Inc | 18,000 | 82.42 USD | |
| 17 Feb 2026 | EXERCISE | Protagonist Therapeutics, Inc | 18,000 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Protagonist Therapeutics, Inc | 2,695 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Protagonist Therapeutics, Inc | 3,762 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Protagonist Therapeutics, Inc | 5,130 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Protagonist Therapeutics, Inc | 6,584 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Protagonist Therapeutics, Inc | 25,700 | 0.00 USD | deriv |
| 16 Jan 2023 | GRANT_AWARD | Protagonist Therapeutics, Inc | 30,000 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Protagonist Therapeutics, Inc | 20,000 | 0.00 USD | deriv |
| 08 Feb 2022 | CONVERSION | Arcellx, Inc. | 2,095,114 | 0.00 USD | |
| 08 Feb 2022 | CONVERSION | Arcellx, Inc. | 931,228 | 0.00 USD | deriv |
| 08 Feb 2022 | CONVERSION | Arcellx, Inc. | 1,163,886 | 0.00 USD | deriv |
| 27 May 2021 | GRANT_AWARD | Protagonist Therapeutics, Inc | 18,000 | 0.00 USD | deriv |
| 11 May 2021 | GRANT_AWARD | Neurogene Inc. | 25,000 | 0.00 USD | deriv |
| 28 May 2020 | GRANT_AWARD | Protagonist Therapeutics, Inc | 15,000 | 0.00 USD | deriv |
| 05 May 2020 | GRANT_AWARD | Neurogene Inc. | 25,000 | 0.00 USD | deriv |
| 10 Oct 2019 | GRANT_AWARD | Neurogene Inc. | 22,000 | 0.00 USD | deriv |
| 01 Sept 2019 | TAX_WITHHOLDING | FIVE PRIME THERAPEUTICS INC | 7,024 | 5.43 USD | |
| 10 Jun 2019 | GRANT_AWARD | FIVE PRIME THERAPEUTICS INC | 15,000 | 0.00 USD | deriv |
| 07 Jun 2019 | GRANT_AWARD | Protagonist Therapeutics, Inc | 12,000 | 0.00 USD | deriv |
| 26 Feb 2019 | TAX_WITHHOLDING | FIVE PRIME THERAPEUTICS INC | 926 | 11.95 USD | |
| 05 Feb 2019 | TAX_WITHHOLDING | FIVE PRIME THERAPEUTICS INC | 3,144 | 11.43 USD | |
| 05 Nov 2018 | EXERCISE | FIVE PRIME THERAPEUTICS INC | 91,217 | 4.56 USD | |
| 05 Nov 2018 | EXERCISE | FIVE PRIME THERAPEUTICS INC | 91,217 | 0.00 USD | deriv |